Soybean trypsin inhibitor (STI) was immobilized on the agarose gel modified with spiropyran compound (spiropyran gel), and photocontrolled binding and releasing oftrypsin was examined. The STI-spiropyran gel showed reverse photochromism. Trypsin was bound on the STI-spiropyran gel in the dark and re
Affinity purification of urinary trypsin inhibitor from human urine
✍ Scribed by Yu Xin; Hailin Yang; Xiaole Xiao; Ling Zhang; Yuran Zhang; Yanjun Tong; Yi Chen; Wu Wang
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 205 KB
- Volume
- 35
- Category
- Article
- ISSN
- 1615-9306
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Affinity protocols for the purification of urinary trypsin inhibitor (UTI) were developed. To imitate the substrate/inhibitor‐binding domain (S1 domain) of trypsin and chymotrypsin, the key amino acid residues were composed to sorbents. The sorbents were then subjected to adsorption analysis with UTI. The purification process consisted of one step of affinity chromatography and another step of ultrafiltration. The purified enzyme was subjected to SDS‐PAGE, trypsin inhibitor activity and peptide map fingerprinting analysis. As calculated, the theoretical maximum adsorption (Q~max~) of two affinity sorbents entitled as S‐D‐G and S‐S‐G were 31.7 and 30.1 mg/g, respectively; the desorption constants K~d~ of the two sorbents were 8.9 and 18.6 μg/mL, respectively. After the separation of UTI with S‐D‐G and S‐S‐G, reducing SDS‐PAGE analysis revealed that the protein was a single polypeptide with the mass of ∼66 kDa, and the purified proteins were ∼95 and 97% pure, respectively; the band on gel was further confirmed with peptide map fingerprinting analysis. Protein and bioactivity recoveries were 1.3 and 75.9% with S‐D‐G, 1.0 and 70.2% with S‐S‐G, respectively.
📜 SIMILAR VOLUMES
## Abstract Previous publications from our laboratory have demonstrated the presence of antigens in the urine of cancer patients detectable by the complement fixation (CF) assay. The purpose of this study was to develop a methodology for purification of these tumor‐associated antigen(s) using xenog